Ipratropium/salbutamol "Orion" 0,5+2,5 mg/beholder inhalationsvæske til nebulisator, opløsning, enkeltdosisbeholder Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

ipratropium/salbutamol "orion" 0,5+2,5 mg/beholder inhalationsvæske til nebulisator, opløsning, enkeltdosisbeholder

orion corporation - ipratropiumbromid, salbutamolsulfat - inhalationsvæske til nebulisator, opløsning, enkeltdosisbeholder - 0,5+2,5 mg/beholder

Bupivacaine "Noridem" 2,5 mg/ml injektionsvæske, opløsning Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

bupivacaine "noridem" 2,5 mg/ml injektionsvæske, opløsning

noridem enterprises ltd. - bupivacainhydrochlorid monohydrat - injektionsvæske, opløsning - 2,5 mg/ml

Bupivacaine "Noridem" 5 mg/ml injektionsvæske, opløsning Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

bupivacaine "noridem" 5 mg/ml injektionsvæske, opløsning

noridem enterprises ltd. - bupivacainhydrochlorid monohydrat - injektionsvæske, opløsning - 5 mg/ml

Natriumchlorid "Noridem" 9 mg/ml solvens til parenteral anvendelse/injektionsvæske, opløsning Δανία - Δανικά - Lægemiddelstyrelsen (Danish Medicines Agency)

natriumchlorid "noridem" 9 mg/ml solvens til parenteral anvendelse/injektionsvæske, opløsning

noridem enterprises ltd. - natriumchlorid - solvens til parenteral anvendelse/injektionsvæske, opløsning - 9 mg/ml

Ucedane Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

ucedane

eurocept international bv - cargluminsyre - hyperammonemia; amino acid metabolism, inborn errors - andre alimentary tract and metabolism produkter, - ucedane is indicated in treatment of:hyperammonaemia due to n-acetylglutamate synthase primary deficiency;hyperammonaemia due to isovaleric acidaemia;hyperammonaemia due to methymalonic acidaemia;hyperammonaemia due to propionic acidaemia.

Regkirona Ευρωπαϊκή Ένωση - Δανικά - EMA (European Medicines Agency)

regkirona

celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - immune sera og immunoglobuliner, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.